Tenofovir was detected in the cervicovaginal fluid samples of 7 of the 29 women (24%) assigned to tenofovir gel who acquired HSV-2 infection.

Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases ...

A dults with HIV and obesity who switched from an antiretroviral therapy (ART) regimen with an integrase strand transfer ...

Besifovir is in phase 3 clinical trials, while tenofovir exalidex is in early development. Nucleoside/nucleotide analogues for hepatitis B can suppress viral replication during treatment, but they ...

Tenofovir has a favorable resistance profile; it is active against wild-type HIV and a majority of nucleoside-resistant HIV-1 strains, except in patients whose HIV expresses the K65R mutation or ...

Tenofovir + ddI has become a commonly prescribed regimen, but evidence is mounting that it may be problematic. Eugenia Negredo and colleagues previously reported that tenofovir combined with full ...

“Tenofovir use appeared to confer protection against more severe COVID-19 outcomes irrespective of HIV status,” the researchers concluded.

We conducted a randomized, placebo-controlled trial to assess daily treatment with oral tenofovir disoproxil fumarate (TDF), oral tenofovir–emtricitabine (TDF-FTC), or 1% tenofovir (TFV) vaginal ...

A topical gel with anti-HIV activity has been shown to be safe and well tolerated by HIV-positive and HIV-negative women. In a study published in the February 28th edition of AIDS investigators from ...

The use of oral tenofovir-based PrEP for HIV prevention in hepatitis B-endemic countries and in high-risk populations could “markedly decrease” the number of HIV and HBV coinfections ...